Clinical trialObsActive not recruiting
Evaluation of an Early Radiomic Signature in Patients With Metastatic Pancreatic Adenocarcinoma Treated With First-line Chemotherapy
- Outcome
- Ongoing
- Phase
- Obs
- Status
- Active not recruiting
- Study type
- Observational
- Start
- 9 January 2024
- Expected end
- December 2026
- Enrollment
- 400 participants
- Sites
- 1
- Primary outcomes
- Overall survival after diagnosis of pancreatic cancer
- Sponsor
- Other
- Results posted
- No
- Last update
- 21 November 2025
These are registry fields. A trial card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try